To further validate whether PD-1/Al@OV leads to T cell infiltration and consequently enhances the efficacy of sensitizing immune checkpoint inhibitors, we injected U87/luci cells into BALB/c nude mice (which lack T cells) and measured tumor growth over time (Fig. 7A). The gene discussed is PDCD1; the disease is neoplasm.